Hallucinogens and Dissociative Drugs Explained
Hallucinogens are a diverse class of substances — including classic psychedelics like LSD and psilocybin, dissociatives like ketamine and PCP, and MDMA — that alter perception, mood or sense of self. Their pharmacology and dependence risk differ significantly by substance. This page explains how they work, what distinguishes them, and when Holina Rehab’s Dual Treatment approach is appropriate.
- Licensed Facility
- Evidence-Based Care
- Koh Phangan, Thailand
- Dual Treatment Programme
What Are Hallucinogens and How Do They Work?
“Hallucinogens” is an umbrella term covering several pharmacologically distinct groups of substances, not a single drug or a single risk profile. The US National Institute on Drug Abuse (NIDA) divides them into classic psychedelics, which act on the brain’s serotonin system, and dissociative drugs, which act on a different receptor system entirely.
Classic psychedelics — LSD, psilocybin (magic mushrooms), DMT and mescaline — bind to serotonin 5-HT2A receptors, disrupting activity in brain networks involved in self-awareness and sensory processing. This produces the visual and perceptual distortions most people associate with the word “hallucinogen.”
Dissociative drugs — ketamine, PCP and dextromethorphan (DXM) — work differently. They block NMDA glutamate receptors, producing a sense of detachment from the body and environment rather than classic hallucinations. MDMA (ecstasy) is often grouped with hallucinogens in population surveys, but pharmacologically it is closer to a stimulant — it releases serotonin, dopamine and norepinephrine rather than acting on 5-HT2A or NMDA receptors directly. Because these mechanisms differ, so does each substance’s potential for dependence — which is why this page treats them separately rather than as one uniform category.
An estimated 2.6% of people aged 12 and older in the US (about 7.4 million people) reported past-year hallucinogen use in 2021, with use among young adults reaching an all-time high since national surveys began tracking the category in 1988 (NIDA). More recent substance-by-substance tracking from 2021–2023 found ketamine use rising (1.61% to 1.91%) while LSD use declined (0.88% to 0.58%) — a reminder that trends, and risk, vary by substance (Chen, Berg & Yang, Drug and Alcohol Dependence Reports, 2026).
Types of Hallucinogens
The substances grouped under “hallucinogens” range from drugs with very low physical dependence potential to drugs with well-established patterns of dependence. Here is how the main sub-categories differ.
Classic Psychedelics
LSD, psilocybin (magic mushrooms), DMT, mescaline. Act on serotonin 5-HT2A receptors. NIDA states that use of psilocybin and LSD “does not typically lead to addiction,” and no physical withdrawal syndrome has been identified for this group.
Risks are primarily psychological — frightening “bad trips,” triggering of psychosis in vulnerable individuals, and rarely, Hallucinogen Persisting Perception Disorder (HPPD). In Thailand, psilocybin and mescaline are Category 1 controlled substances with no recognised medical use (Thai FDA).
Dissociative Hallucinogens
Ketamine, PCP, DXM. Block NMDA glutamate receptors, producing detachment rather than classic hallucinations. Unlike classic psychedelics, regular non-clinical ketamine use has been linked to cravings and withdrawal-type symptoms (NIDA), and PCP carries an established use-disorder diagnosis.
Ketamine also carries serious physical risks with regular heavy use, including bladder damage. See our dedicated Ketamine Addiction Treatment and Ketamine Detox pages for the specific risks and our treatment pathway.
MDMA & Related Entactogens
MDMA (ecstasy). Often surveyed alongside hallucinogens, but pharmacologically distinct — it primarily releases serotonin, dopamine and norepinephrine rather than acting directly on 5-HT2A or NMDA receptors. Effects include euphoria and emotional openness rather than classic hallucinations or dissociation.
Heavy or repeated use is associated with depression, anxiety and cognitive effects linked to serotonergic depletion. See our dedicated MDMA & Ecstasy Addiction Treatment page for the full picture and our treatment approach.
Why This Matters for Treatment
Because dependence within this drug class is overwhelmingly psychological rather than physiological — and varies sharply by substance — effective treatment cannot follow a single template. It has to be matched to what a person has actually been using and why.
Matching the Approach to the Substance
-
Classic Psychedelics — Psychological Support, Not Physical Detox
Because there is no established physical withdrawal from LSD or psilocybin, care focuses on processing a difficult experience, screening for underlying psychosis risk, and addressing the anxiety, trauma or compulsive-use patterns that sometimes accompany frequent use.
-
Dissociatives (Ketamine & PCP) — Medical Oversight and Craving Management
Regular ketamine or PCP use can involve real cravings, tolerance and withdrawal-type symptoms, plus physical complications such as ketamine-related bladder damage. This calls for medically supervised support alongside psychological treatment — see our Ketamine Addiction Treatment programme.
-
Dual Treatment for Co-Occurring Conditions
Across every substance in this class, use that becomes compulsive is frequently intertwined with anxiety, depression or unresolved trauma. Our Dual Treatment programme addresses the substance use and the underlying condition together, rather than treating either in isolation.
A Different Kind of Recovery
Licensed Medical Facility
Holina Rehab is fully licensed by the Thai Ministry of Public Health and operates under international addiction treatment standards. Our on-site physician, nursing staff, and experienced addiction therapists provide 24-hour clinical oversight, whatever the substance involved.
Whether the presenting substance is a classic psychedelic, a dissociative like ketamine, or MDMA, assessment, dual treatment for any co-occurring condition, and evidence-based therapy are delivered within a single integrated residential setting — no referrals, no gaps in care.
The Koh Phangan Recovery Environment
The tropical island setting — sea air, natural surroundings, and distance from daily life — creates conditions for the psychological reset that recovery from any substance requires. Koh Phangan is home to one of Asia’s largest healing communities.
Clients benefit from private beach access, swimming pools, an on-site gym, a nutritious restaurant, and a range of holistic therapies that complement the clinical programme.
Our Clinical Team
Treatment at Holina Rehab is led by qualified medical professionals and experienced addiction therapists. Every client is under active clinical supervision throughout their programme.
Licensed by the Thai Ministry of Public Health · Residential Rehab Licence #84-03-00294 · International Addiction Treatment Standards
“I had an incredible experience here at Holina, really feel my time here was truly transformative.”
— Marlon Hulme, Recovery.com Review, 3 Oct 2025 · ★★★★★
Hallucinogens & Dissociative Drugs: Frequently Asked Questions
Are hallucinogens addictive?
It depends heavily on the specific substance. Classic psychedelics such as LSD and psilocybin are not considered addictive in the way alcohol, opioids or stimulants are — the US National Institute on Drug Abuse (NIDA) states their use “does not typically lead to addiction,” and no physical withdrawal syndrome has been identified for this group. Dissociative drugs such as ketamine and PCP are different: regular non-clinical use has been linked to cravings, tolerance and withdrawal-type symptoms. Anyone experiencing compulsive use of any of these substances can be assessed at Holina Rehab.
What’s the difference between classic psychedelics and dissociative drugs?
Classic psychedelics (LSD, psilocybin, DMT, mescaline) act mainly on serotonin 5-HT2A receptors, producing visual and perceptual changes. Dissociative drugs (ketamine, PCP, DXM) block NMDA glutamate receptors instead, producing a sense of detachment from the body and environment rather than classic hallucinations. The two groups work through different brain systems and carry different dependence risks.
What is Hallucinogen Persisting Perception Disorder (HPPD)?
HPPD is an uncommon condition in which visual disturbances — such as trails, halos or static-like “visual snow” — persist or recur after a person has stopped using a hallucinogen. Clinical literature describes it as rare, and how many users are affected is genuinely debated in the research. It is not a sign of addiction, but it can be distressing and benefits from proper clinical assessment.
Is ketamine or PCP more addictive than LSD or psilocybin?
Yes, meaningfully so. National survey data tracked between 2021 and 2023 shows ketamine use rising while LSD use declined, and research literature associates ketamine and PCP with tolerance, craving and withdrawal-type symptoms not seen with classic psychedelics. If ketamine or PCP use has become compulsive, see our Ketamine Addiction Treatment and Ketamine Detox pages.
Does Holina Rehab treat ketamine or MDMA dependence?
Yes. We treat dependence on ketamine and other dissociative or hallucinogenic substances through our Dual Treatment programme, which addresses the substance use alongside any underlying anxiety, depression or trauma. For ketamine specifically, see our Ketamine Addiction Treatment and Ketamine Detox pages; for MDMA, see MDMA & Ecstasy Addiction Treatment.
What should I do if a hallucinogen experience triggers a mental health crisis?
A frightening “bad trip,” a psychotic episode, or persistent perceptual disturbances after hallucinogen use should be assessed by a medical or mental health professional promptly, particularly for anyone with a personal or family history of psychosis, schizophrenia or bipolar disorder. Contact our clinical team for guidance, or seek local emergency care for any acute crisis.
Ready to Begin Your Recovery?
Our admissions team responds the same day — seven days a week, in full confidence.
+66 (0) 82 113 0657 or contact us online ↓